This research report presents a comprehensive overview on the India Healthcare market, further presents an analysis on its products and services in the market and the leading companies operating in the Healthcare industry. You will also find many facts & figures and statistics related to the India Healthcare market.
Along with a detailed overview, this report also has SWOT analysis and PEST analysis which provide a deeper insightful look into the Indian Healthcare market. There’s also regional analysis which furthermore increases the credibility of the data provided in this report. The data has been presented in such a way that is easy to understand. You will find pie charts, graphs, and other visual representations that will provide better sense of the information.
The research report widely covers the business profiles of all the key players that operate in the India Healthcare market. These companies have been thoroughly profiled and the report contains information on their growth projections, development prospects, their business strategies, sales data, and their current business revenue, to the expected revenue. Based on the report, you can understand what the leading players are planning to do in the next 5 years, and this data will help you to make important business decisions. Apollo Hospitals Enterprise Limited, Aster DM Healthcare Limited, Cipla Limited, Dr. Lal PathLabs Limited, Fortis Healthcare Limited and more - all the top companies operating in the India Healthcare market and their business strategies have been profiled in this research report.
In terms of revenue and employment generation, healthcare has been one of the biggest industries in India. Kerala is one of the states in India that offers outstanding healthcare facilities.
Market insights:
The healthcare market in India was valued at INR 14.32 Tn in 2019 and is expected to expand at a compound annual growth rate (CAGR) of ~34.04% during the 2020-2025 period, to reach INR 65.51 Tn by 2025. The growth of the market can be attributed to the surge in demand for home healthcare devices, digital healthcare solutions and pharmaceutical products. Rise in the prevalence of chronic diseases, growing investments from public and private investors, and the emergence of advanced technologies like telehealth and telemedicine solutions are some of the major factors propelling the growth of the Indian healthcare market. Relaxation of FDI and increased government expenditure are some of the key factors to drive the healthcare market during the 2016-2020 period. However, inadequate healthcare infrastructure in India and low penetration of health insurance are impeding market growth.
Segment Insights:
The healthcare market in India is segmented into outpatient care centers, hospitals, pharmaceuticals, medical equipment and supplies, diagnostic services, digital healthcare, research and development, medical insurance and medical tourism. As of 2019, the healthcare market was dominated by the hospitals segment, which accounted for about 38.50% of the total market revenue. By 2025, the market share of the hospitals segment is expected to decline by ~10.55% to hold around 27.95% of the overall healthcare market revenue. During the 2020-2025 period, the digital healthcare segment is anticipated to become the fastest growing segment in the market as a result of the self-isolation norms imposed to restrain the spread of COVID-19 and the cost-benefit obtained from using digital healthcare solutions. Other segments of the market which are expected to witness high growth rate during the forecast period are the pharmaceuticals, and medical equipment and supplies segments.
COVID-19 impact analysis:
The outbreak of the contagion, followed by a long-term nationwide lockdown has had a severe impact on the overall healthcare market in India. The market segments that are likely to be positively impacted during the pandemic and the period thereafter are the digital healthcare segment, pharmaceuticals, medical equipment and supplies segment. The medical research and development (R&D) segment and the medical insurance segments are expected to experience a relatively short-term benefit during this crisis period. The medical R&D segment and the insurance segment are some of the least prioritized segments of the Indian healthcare industry and hence, the impact of COVID-19 on these segments are expected plunge with the diminishing effect of the pandemic. Other healthcare segments such as hospitals, medical tourism, and outpatient care centers are witnessing severe downfall in their markets due to the risk of virus transmission from social gatherings and the imposition of the social distancing norms.
Companies covered
• Apollo Hospitals Enterprise Limited
• Aster DM Healthcare Limited
• Cipla Limited
• Dr. Lal PathLabs Limited
• Fortis Healthcare Limited
• Healthcare Global Enterprises Limited
• Narayana Hrudayalaya Limited
• Sun Pharmaceuticals Industries Limited
• Columbia Asia Hospitals Private Limited
• Max Healthcare Private Limited
With this research report, you can get an insightful view of the India Healthcare market. So, if you are looking to make smart investments, you will be at an advantage with all the relevant data at your fingertips. This report also contains market analysis, growth analysis, and competitive landscape report, so if you are looking to start your own business in the India Healthcare market, you can use this report to assess business opportunities and make business strategies.
This market research report has been prepared by the best researchers and authors of the research & development industry. They are qualified and have years of experience conducting detailed research. Market Research Port has many protocols in place to ensure that the reports are fact-checked before they are published and sold. At Market Research Port, we have exclusive tie-ups with some of the best research authors and bring to you only the finest reports at the most affordable prices. To Purchase the research report on India Healthcare market, Get in touch with us today.
Chapter 1: Executive summary
Chapter 2: Socio-economic indicators
Chapter 3: Introduction
3.1. Market definition and structure
Chapter 4: Market overview
4.1. India healthcare market – overview
4.1.1. Market size and growth forecast based on value (2018-2025)
4.1.2. Major health cities in India
Chapter 5: Impact of COVID-19
5.1. Impact of COVID-19
5.2. Companies manufacturing COVID-19 antiviral drugs
5.3. Companies developing vaccines against COVID-19
5.4. Companies developing COVID-19 test kits
5.5. Indian government initiatives against COVID-19
5.6. International relationship development as a result of COVID-19
Chapter 6: Market segmentation
6.1. Healthcare market in India – segmentation
6.1.1. India healthcare market share based on type (2018-2025)
6.1.2. India outpatient care services market size and growth forecast (2018-2025)
6.1.3. India hospitals market size and growth forecast (2018-2025)
6.1.4. India pharmaceuticals market size and growth forecast (2018-2025)
6.1.5. India medical equipment and supplies market size and growth forecast (2018-2025)
6.1.6. India diagnostic services market size and growth forecast (2018-2025)
6.1.7. India digital healthcare market size and growth forecast (2018-2025)
6.1.8. India medical research and development market size and growth forecast (2018-2025)
6.1.9. India medical insurance market size and growth forecast (2018-2025)
6.1.10. India medical tourism market size and growth forecast (2018-2025)
Chapter 7: Market influencers
7.1. Market drivers
7.2. Market challenges
Chapter 8: Government initiatives
8.1. Government initiatives
8.2. Upcoming healthcare projects in India
Chapter 9: Market trends
9.1. Market trends
Chapter 10: Competitive landscape
10.1. Key players in the market
10.1.1. Apollo Hospitals Enterprise Limited
Company information
Business description
Products/services
Key people
Financial snapshot
Key business segments
Key geographical segments
Note: Financial data and segment-wise data is available for public companies only
10.1.2. Aster DM Healthcare Limited
10.1.3. Cipla Limited
10.1.4. Dr. Lal PathLabs Limited
10.1.5. Fortis Healthcare Limited
10.1.6. Healthcare Global Enterprises Limited
10.1.7. Narayana Hrudayalaya Limited
10.1.8. Sun Pharmaceuticals Industries Limited
10.1.9. Columbia Asia Hospitals Private Limited
10.1.10. Max Healthcare Private Limited
Chapter 11: Merger and acquisitions
11.1. Merger and acquisitions
Chapter 12: Funding and investments
12.1. Funding and investments
Chapter 13: Recent developments
13.1. Recent developments
Chapter 14: Appendix
14.1. Research methodology
14.2. About Netscribes
14.3. Disclaimer